Go Pro

Oppenheimer Asset Management Inc. Buys Shares of 400,910 Cognex Corporation $CGNX

Cognex logo with Technology background
Image from MarketBeat Media, LLC.

Oppenheimer Asset Management Inc. purchased a new position in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 400,910 shares of the scientific and technical instruments company's stock, valued at approximately $29,034,000. Oppenheimer Asset Management Inc. owned about 0.24% of Cognex as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CGNX. Geneos Wealth Management Inc. increased its position in shares of Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock worth $27,000 after buying an additional 736 shares during the period. Elevation Wealth Partners LLC raised its stake in Cognex by 635.4% during the second quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company's stock worth $35,000 after buying an additional 413 shares during the last quarter. CIBC Private Wealth Group LLC lifted its holdings in Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company's stock valued at $35,000 after buying an additional 327 shares during the period. Cassaday & Co Wealth Management LLC acquired a new position in Cognex in the first quarter valued at $36,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Cognex in the fourth quarter valued at $39,000. Institutional investors and hedge funds own 88.12% of the company's stock.

Cognex Stock Up 6.6%

Shares of NASDAQ CGNX opened at $65.63 on Friday. The firm has a market cap of $11.04 billion, a PE ratio of 63.72 and a beta of 1.49. The company's fifty day simple moving average is $64.87 and its 200 day simple moving average is $57.95. Cognex Corporation has a 12-month low of $34.60 and a 12-month high of $72.88.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.42 by $0.03. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The firm had revenue of $291.26 million during the quarter, compared to the consensus estimate of $292.10 million. During the same period in the previous year, the firm posted $0.25 earnings per share. The business's revenue was up 16.9% compared to the same quarter last year. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. On average, equities analysts predict that Cognex Corporation will post 1.68 earnings per share for the current year.

Cognex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Thursday, August 20th will be given a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend is Thursday, August 20th. Cognex's payout ratio is presently 33.01%.

Insiders Place Their Bets

In related news, VP Darren Marc Long sold 20,252 shares of the company's stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the transaction, the vice president directly owned 3,990 shares of the company's stock, valued at approximately $264,696.60. This represents a 83.54% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.70% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on CGNX shares. Robert W. Baird set a $72.00 price target on Cognex in a report on Friday, May 8th. The Goldman Sachs Group reissued a "buy" rating and issued a $91.00 price objective on shares of Cognex in a research note on Friday, August 7th. Cantor Fitzgerald upped their target price on Cognex from $76.00 to $84.00 and gave the company an "overweight" rating in a research report on Friday, August 7th. DA Davidson set a $65.00 target price on Cognex and gave the company a "neutral" rating in a research report on Monday. Finally, Weiss Ratings raised Cognex from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and five have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $75.64.

Get Our Latest Report on Cognex

About Cognex

(Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Recommended Stories

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Cognex Right Now?

Before you consider Cognex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.

While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines